AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...

Drugs giant AstraZeneca has revealed plans to overhaul its US listing, but stressed it will keep its headquarters in the UK and remain on the London market. Cambridge-based AstraZeneca is set to ...

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (AZN) today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access ...

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the ...

AstraZeneca reported Q3 earnings of $1.04 per share, beating Zacks Consensus Estimate of $1.01. Revenues rose across all segments with sales of many key drugs, including Tagrisso, Fasenra and Farxiga.

Pharmaceutical giant AstraZeneca (NASDAQ:AZN) said on Monday that it plans to make investments worth $50B in the United States by 2030. This investment is expected to create tens of thousands of new, ...

In July, AstraZeneca announced plans to invest $50 billion by 2030 on boosting its US manufacturing and research operations - Copyright AFP Tobias SCHWARZ In July ...

FILE PHOTO: Exterior photos of the North America headquarters of AstraZeneca (Reuters) -AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug ...

AstraZeneca's announcement included a new factory in the US state of Virginia, which will be the company's 'largest single manufacturing investment' - Copyright AFP ...

LONDON (Reuters) -AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices for millions of ...